Identification and Confirmation of Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 Rearrangement and Characterization of Treatment Patterns and Outcomes in a Real-World Setting: A US Retrospective Chart Review.
Sign Up to like & getrecommendations! Published in 2025 at "Acta haematologica"
DOI: 10.1159/000546910
Abstract: INTRODUCTION Myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement (MLN-FGFR1) are rare, heterogenous, aggressive hematologic malignancies with FGFR1 rearrangements at the 8p11 locus. Pemigatinib, a potent selective inhibitor of FGFR1-3, is approved for relapsed/refractory… read more here.
Keywords: lymphoid neoplasms; fibroblast growth; mln fgfr1; neoplasms fibroblast ... See more keywords